Release date : 2019/2/24 10:28:18
Recently, the pharmaceutical industry has issued a series of favorable policies, such as the “Twelfth Five-Year Plan for Pharmaceutical Circulation” and the just-published “Twelfth Five-Year Plan for Medical Science and Technology Development”, and the future policies will include “Biomedicine”. The “Twelfth Five-Year Plan” for industrial development, the “Special Plan for Scientific and Technological Development of Medical Device Industry 2011-2015” and the “Twelfth Five-Year Plan for Pharmaceutical Packaging Industry”.
Guo Fanli, a researcher in the pharmaceutical industry of China Investment Consulting, pointed out that at present, the growth rate of the domestic medical device industry is around 25%, and the growth rate is obvious. The domestic medical device industry has also formed 47 large categories, more than 3,000 varieties, and more than 11,000 specifications. The number of related production companies has also exceeded 12,000. However, it should be noted that in developed countries, the consumption ratio of medical devices and drugs is almost 1:1, but in China, the ratio is only 1:10. It can be seen that there is still a big gap in China's medical device industry.
Guo Fanli pointed out that in addition to the fact that the consumption ratio is far from that of developed countries, China's medical device industry still has a late start time, poor innovation ability, weak R&D level, lack of relevant talents, etc.; on the other hand, due to the lack of strict access regulations and The lack of government supervision of medical devices has led to chaos in China's medical device market. Since the introduction of the new medical reform, multinational pharmaceutical groups have accelerated the pace of entering the medical device market in China, which has also seized the market share of many domestic medical device companies. The forthcoming "Special Plan for the Development of Science and Technology for the Medical Device Industry 2011-2015" will improve the current competitive landscape of the medical device industry in the above aspects, and at the same time accelerate the development of related enterprises. In the just-released "Twelfth Five-Year Plan for Medical Science and Technology Development", we can already see the government's support for the medical device industry, especially the basic medical device companies, such as related companies such as Yuyue Medical and Yangpu Medical. Waiting for the development will be good.
Guo Fanli said that in the first three quarters of this year, the domestic medical device industry revenue and the main business net profit growth rate were 39% and 22%, respectively, and the fastest growth rate among the sub-sectors of the pharmaceutical industry. Under the background of the new medical reform, the domestic There are still a large number of medical device products in various provinces and cities ready to be upgraded and upgraded, which also brings benefits to related companies. However, foreign-funded enterprises have also changed their strategies to get involved in the grass-roots market that was not interested before, and developed targeted medical device products. It is also a challenge for the domestic medical device industry.